Key result
Angiotensin signaling blockade improves insulin sensitivity in metabolic syndrome.
Answers are grounded in this paper and cite their sources.
Insulin resistance or its sequelae may be the common etiology of maladies associated with metabolic syndrome (eg, hypertension, type 2 diabetes, atherosclerosis, heart attack, stroke, and kidney failure). It is thus important to understand those factors that affect insulin sensitivity. This review stems from the surprising discovery that interference with angiotensin signaling improves insulin sensitivity, and it provides a general overview of insulin action and factors that control insulin sensitivity.
No takes yet. Share an insight, caveat, or question.
Elmus Beale (2013) conducted a review in Insulin resistance and metabolic syndrome. Interference with angiotensin signaling was evaluated on Insulin sensitivity. Interference with angiotensin signaling improves insulin sensitivity, prompting an overview of insulin action and regulatory factors in metabolic syndrome.
Synapse has enriched 10 related papers. Consider them for comparative context: